Uri Lopatin

Founder & CEO

Founder and original CEO of Pardes Biosciences. Physician-scientist who previously held roles at Gilead Sciences and Schering-Plough, and co-founded Assembly Biosciences. Founded Pardes in 2020 to develop oral antiviral treatments for COVID-19.

Overview

Companies
1
Roles
Founder & CEO

Companies

1 company
Pardes Biosciences $127M
Acquired Founder & CEO

Clinical-stage biopharmaceutical company that developed novel oral antiviral therapeutics targeting COVID-19. Went public via SPAC merger in 2021 before being acquired by MediPacific (a Foresite Capital affiliate) in 2023 after its lead candidate failed Phase 2 trials.

Founder data is compiled from company records, public announcements, and verified sources. Roles reflect current or most recent known positions.